Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BillionToOne, Inc.BLLN · Entity 3992 | See Remarks | October 08, 2026 | October 13, 2026 |
| Nuwellis, Inc.CHFS · Entity 8478 | Chief Legal Compliance Officer | January 22, 2021 | January 27, 2021 |
| Orexigen Therapeutics, Inc.OREX · Entity 157016 | EVP, Chief Admin Off, GC & Sec | October 13, 2017 | October 17, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BillionToOne, Inc.
Report date October 08, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 8,700 |
Reported balance
After 2026-10-08 transaction · row 1
1 source rowRow 1 · 2026-10-08 · Exercise / conversion · Acquired 8,000 · Balance 8,700 |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.65 · Expires 2033-01-18 | Direct | 40,974 |
Reported balance
After 2026-10-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-10-08 · Exercise / conversion · Disposed 8,000 · Balance 40,974 F1: The options are fully vested and exercisable. The terms of the underlying option grant are as previously reported on the Reporting Person's Form 3 filed on November 5, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The options are fully vested and exercisable. The terms of the underlying option grant are as previously reported on the Reporting Person's Form 3 filed on November 5, 2025.
Nuwellis, Inc.
Report date January 22, 2021 · Filed January 27, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Incentive Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $9.30 · Expires 2031-01-21 | Direct | 7,000 |
Reported balance
After 2021-01-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-01-22 · Grant · Acquired 7,000 · Balance 7,000 F1: The options will vest as follows: 25% of the options will vest on the one-year anniversary of the date of grant; the remaining options will vest in 36 equal consecutive monthly increments thereafter, so all will be vested on the four-year anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The options will vest as follows: 25% of the options will vest on the one-year anniversary of the date of grant; the remaining options will vest in 36 equal consecutive monthly increments thereafter, so all will be vested on the four-year anniversary of the date of grant.
Orexigen Therapeutics, Inc.
Report date October 13, 2017 · Filed October 17, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Unit (RSU)SEC Table II · derivative / convertible security | Direct | 69,600 |
Reported balance
After 2017-10-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-10-13 · Grant · Acquired 69,600 · Balance 69,600 F1: Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F2: Reflects an award of restricted stock units ("RSUs"), each representing a contingent right to receive a share of the issuer's common stock upon settlement. F3: Twenty-five percent (25%) of the RSUs will vest on each of the first four (4) anniversaries of February 3, 2018 (each, a "Vesting Date"), subject to the reporting person's continued eligibility on each applicable Vesting Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
F2: Reflects an award of restricted stock units ("RSUs"), each representing a contingent right to receive a share of the issuer's common stock upon settlement.
F3: Twenty-five percent (25%) of the RSUs will vest on each of the first four (4) anniversaries of February 3, 2018 (each, a "Vesting Date"), subject to the reporting person's continued eligibility on each applicable Vesting Date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 08, 2026 Filed Oct 13, 2026 22:39 UTC | BillionToOne, Inc. BLLN · Entity 3992 | Exercise / conversionStock Option (right to buy) · Derivative | 8,000 | $8.65 Strike: $8.65 | $69,200.00 |
DisclosureSEC source: 0002070849-26-000071 · wk-form4_1791931182.xml · derivative · entry 2 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,974 Underlying: Class A Common Stock · 8,000 shares Expires 2033-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options are fully vested and exercisable. The terms of the underlying option grant are as previously reported on the Reporting Person's Form 3 filed on November 5, 2025. Read SEC document |
| October 08, 2026 Filed Oct 13, 2026 22:39 UTC | BillionToOne, Inc. BLLN · Entity 3992 | Exercise / conversionClass A Common Stock | 8,000 | $8.65 | $69,200.00 |
DisclosureSEC source: 0002070849-26-000071 · wk-form4_1791931182.xml · nonDerivative · entry 1 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2026 Filed Sep 21, 2026 23:00 UTC | BillionToOne, Inc. BLLN · Entity 3992 | Exercise / conversionStock Option (right to buy) · Derivative | 5,840 | $30.78 Strike: $30.78 | $179,755.20 |
DisclosureSEC source: 0002070849-26-000069 · wk-form4_1790031608.xml · derivative · entry 12 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,834 Underlying: Class A Common Stock · 5,840 shares Expires 2035-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options are fully vested and exercisable. The terms of the underlying option grant are as previously reported on the Reporting Person's Form 3 filed on November 5, 2025. Read SEC document |
| September 17, 2026 Filed Sep 21, 2026 23:00 UTC | BillionToOne, Inc. BLLN · Entity 3992 | Exercise / conversionStock Option (right to buy) · Derivative | 2,920 | $17.12 Strike: $17.12 | $49,990.40 |
DisclosureSEC source: 0002070849-26-000069 · wk-form4_1790031608.xml · derivative · entry 11 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,417 Underlying: Class A Common Stock · 2,920 shares Expires 2034-10-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options are fully vested and exercisable. The terms of the underlying option grant are as previously reported on the Reporting Person's Form 3 filed on November 5, 2025. Read SEC document |
| September 17, 2026 Filed Sep 21, 2026 23:00 UTC | BillionToOne, Inc. BLLN · Entity 3992 | Exercise / conversionStock Option (right to buy) · Derivative | 6,968 | $11.55 Strike: $11.55 | $80,480.40 |
DisclosureSEC source: 0002070849-26-000069 · wk-form4_1790031608.xml · derivative · entry 10 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,063 Underlying: Class A Common Stock · 6,968 shares Expires 2033-10-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options are fully vested and exercisable. The terms of the underlying option grant are as previously reported on the Reporting Person's Form 3 filed on November 5, 2025. Read SEC document |
| September 17, 2026 Filed Sep 21, 2026 23:00 UTC | BillionToOne, Inc. BLLN · Entity 3992 | Exercise / conversionStock Option (right to buy) · Derivative | 19,384 | $8.65 Strike: $8.65 | $167,671.60 |
DisclosureSEC source: 0002070849-26-000069 · wk-form4_1790031608.xml · derivative · entry 9 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,974 Underlying: Class A Common Stock · 19,384 shares Expires 2033-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options are fully vested and exercisable. The terms of the underlying option grant are as previously reported on the Reporting Person's Form 3 filed on November 5, 2025. Read SEC document |
| September 17, 2026 Filed Sep 21, 2026 23:00 UTC | BillionToOne, Inc. BLLN · Entity 3992 | SaleClass A Common Stock | 5,840 | $110.29 | $644,111.70 |
DisclosureSEC source: 0002070849-26-000069 · wk-form4_1790031608.xml · nonDerivative · entry 8 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 700 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.000 to $110.970 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 17, 2026 Filed Sep 21, 2026 23:00 UTC | BillionToOne, Inc. BLLN · Entity 3992 | SaleClass A Common Stock | 2,920 | $110.31 | $322,100.24 |
DisclosureSEC source: 0002070849-26-000069 · wk-form4_1790031608.xml · nonDerivative · entry 7 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,540 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.000 to $110.890 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 17, 2026 Filed Sep 21, 2026 23:00 UTC | BillionToOne, Inc. BLLN · Entity 3992 | SaleClass A Common Stock | 6,968 | $110.30 | $768,560.64 |
DisclosureSEC source: 0002070849-26-000069 · wk-form4_1790031608.xml · nonDerivative · entry 6 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,460 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.000 to $110.890 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 17, 2026 Filed Sep 21, 2026 23:00 UTC | BillionToOne, Inc. BLLN · Entity 3992 | SaleClass A Common Stock | 19,384 | $110.36 | $2,139,193.04 |
DisclosureSEC source: 0002070849-26-000069 · wk-form4_1790031608.xml · nonDerivative · entry 5 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,428 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.000 to $110.970 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 17, 2026 Filed Sep 21, 2026 23:00 UTC | BillionToOne, Inc. BLLN · Entity 3992 | Exercise / conversionClass A Common Stock | 5,840 | $30.78 | $179,755.20 |
DisclosureSEC source: 0002070849-26-000069 · wk-form4_1790031608.xml · nonDerivative · entry 4 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. Read SEC document |
| September 17, 2026 Filed Sep 21, 2026 23:00 UTC | BillionToOne, Inc. BLLN · Entity 3992 | Exercise / conversionClass A Common Stock | 2,920 | $17.12 | $49,990.40 |
DisclosureSEC source: 0002070849-26-000069 · wk-form4_1790031608.xml · nonDerivative · entry 3 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. Read SEC document |
| September 17, 2026 Filed Sep 21, 2026 23:00 UTC | BillionToOne, Inc. BLLN · Entity 3992 | Exercise / conversionClass A Common Stock | 6,968 | $11.55 | $80,480.40 |
DisclosureSEC source: 0002070849-26-000069 · wk-form4_1790031608.xml · nonDerivative · entry 2 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. Read SEC document |
| September 17, 2026 Filed Sep 21, 2026 23:00 UTC | BillionToOne, Inc. BLLN · Entity 3992 | Exercise / conversionClass A Common Stock | 19,384 | $8.65 | $167,671.60 |
DisclosureSEC source: 0002070849-26-000069 · wk-form4_1790031608.xml · nonDerivative · entry 1 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | Exercise / conversionStock Option (right to buy) · Derivative | 3,326 | $30.78 Strike: $30.78 | $102,374.28 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · derivative · entry 21 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,674 Underlying: Class A Common Stock · 3,326 shares Expires 2035-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options are fully vested and exercisable. The terms of the underlying option grant are as previously reported on the Reporting Person's Form 3 filed on November 5, 2025. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | Exercise / conversionStock Option (right to buy) · Derivative | 1,663 | $17.12 Strike: $17.12 | $28,470.56 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · derivative · entry 20 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,337 Underlying: Class A Common Stock · 1,663 shares Expires 2034-10-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options are fully vested and exercisable. The terms of the underlying option grant are as previously reported on the Reporting Person's Form 3 filed on November 5, 2025. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | Exercise / conversionStock Option (right to buy) · Derivative | 3,969 | $11.55 Strike: $11.55 | $45,841.95 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · derivative · entry 19 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,031 Underlying: Class A Common Stock · 3,969 shares Expires 2033-10-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options are fully vested and exercisable. The terms of the underlying option grant are as previously reported on the Reporting Person's Form 3 filed on November 5, 2025. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | Exercise / conversionStock Option (right to buy) · Derivative | 11,042 | $8.65 Strike: $8.65 | $95,513.30 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · derivative · entry 18 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,358 Underlying: Class A Common Stock · 11,042 shares Expires 2033-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options are fully vested and exercisable. The terms of the underlying option grant are as previously reported on the Reporting Person's Form 3 filed on November 5, 2025. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | SaleClass A Common Stock | 232 | $100.92 | $23,414.41 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · nonDerivative · entry 17 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 700 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F11 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.725 to $101.650 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | SaleClass A Common Stock | 2,518 | $100.20 | $252,293.28 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · nonDerivative · entry 16 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 932 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F10 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.670 to $100.550 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | SaleClass A Common Stock | 576 | $98.89 | $56,959.60 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · nonDerivative · entry 15 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,450 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.340 to $99.230 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | SaleClass A Common Stock | 147 | $101.41 | $14,906.93 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · nonDerivative · entry 14 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,026 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F9 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.890 to $101.870 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | SaleClass A Common Stock | 1,131 | $100.33 | $113,468.82 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · nonDerivative · entry 13 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,173 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F8 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.830 to $100.790 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | SaleClass A Common Stock | 385 | $99.22 | $38,200.86 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · nonDerivative · entry 12 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,304 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.830 to $99.825 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | SaleClass A Common Stock | 358 | $100.82 | $36,094.78 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · nonDerivative · entry 11 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,689 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F6 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.720 to $100.9025 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | SaleClass A Common Stock | 2,997 | $100.11 | $300,040.16 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · nonDerivative · entry 10 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,047 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.585 to $100.565 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | SaleClass A Common Stock | 614 | $99.00 | $60,785.14 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · nonDerivative · entry 9 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,044 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.340 to $99.195 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | SaleClass A Common Stock | 775 | $100.83 | $78,142.40 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · nonDerivative · entry 8 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,658 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.620 to $100.9125 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | SaleClass A Common Stock | 8,285 | $100.12 | $829,517.40 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · nonDerivative · entry 7 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,433 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.585 to $100.565 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | SaleClass A Common Stock | 1,944 | $98.97 | $192,390.29 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · nonDerivative · entry 6 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,718 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.340 to $99.230 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | SaleClass A Common Stock | 38 | $96.47 | $3,666.01 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · nonDerivative · entry 5 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,662 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | Exercise / conversionClass A Common Stock | 3,326 | $30.78 | $102,374.28 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · nonDerivative · entry 4 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | Exercise / conversionClass A Common Stock | 1,663 | $17.12 | $28,470.56 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · nonDerivative · entry 3 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | Exercise / conversionClass A Common Stock | 3,969 | $11.55 | $45,841.95 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · nonDerivative · entry 2 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,711 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 23:44 UTC | BillionToOne, Inc. BLLN · Entity 3992 | Exercise / conversionClass A Common Stock | 11,042 | $8.65 | $95,513.30 |
DisclosureSEC source: 0002070849-26-000067 · wk-form4_1789083874.xml · nonDerivative · entry 1 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 23:16 UTC | BillionToOne, Inc. BLLN · Entity 3992 | OtherStock Option (right to buy) · Derivative | 40,000 | Not disclosed Strike: $30.78 | Not disclosed |
DisclosureSEC source: 0001193125-25-278144 · ownership.xml · derivative · entry 11 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Class A Common Stock · 40,000 shares Expires 2035-09-30 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). F1 · price: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). F6 · derivative.exercise_date: The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period. The options vest and become exercisable in equal monthly installments commencing on September 15, 2025, subject to the Reporting Person's continuous service with the Issuer through each such vesting date. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 23:16 UTC | BillionToOne, Inc. BLLN · Entity 3992 | OtherStock Option (right to buy) · Derivative | 40,000 | Not disclosed Strike: $30.78 | Not disclosed |
DisclosureSEC source: 0001193125-25-278144 · ownership.xml · derivative · entry 10 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2035-09-30 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). F1 · price: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). F6 · derivative.exercise_date: The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period. The options vest and become exercisable in equal monthly installments commencing on September 15, 2025, subject to the Reporting Person's continuous service with the Issuer through each such vesting date. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 23:16 UTC | BillionToOne, Inc. BLLN · Entity 3992 | OtherStock Option (right to buy) · Derivative | 10,000 | Not disclosed Strike: $17.12 | Not disclosed |
DisclosureSEC source: 0001193125-25-278144 · ownership.xml · derivative · entry 9 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 10,000 shares Expires 2034-10-16 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). F1 · price: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). F5 · derivative.exercise_date: The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period. The options vest and become exercisable in equal monthly installments commencing on October 6, 2024, subject to the Reporting Person's continuous service with the Issuer through each such vesting date. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 23:16 UTC | BillionToOne, Inc. BLLN · Entity 3992 | OtherStock Option (right to buy) · Derivative | 10,000 | Not disclosed Strike: $17.12 | Not disclosed |
DisclosureSEC source: 0001193125-25-278144 · ownership.xml · derivative · entry 8 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2034-10-16 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). F1 · price: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). F5 · derivative.exercise_date: The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period. The options vest and become exercisable in equal monthly installments commencing on October 6, 2024, subject to the Reporting Person's continuous service with the Issuer through each such vesting date. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 23:16 UTC | BillionToOne, Inc. BLLN · Entity 3992 | OtherStock Option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $11.55 | Not disclosed |
DisclosureSEC source: 0001193125-25-278144 · ownership.xml · derivative · entry 7 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Class A Common Stock · 15,000 shares Expires 2033-10-17 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). F1 · price: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). F4 · derivative.exercise_date: The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period. The options vest and become exercisable in equal monthly installments commencing on October 1, 2023, subject to the Reporting Person's continuous service with the Issuer through each such vesting date. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 23:16 UTC | BillionToOne, Inc. BLLN · Entity 3992 | OtherStock Option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $11.55 | Not disclosed |
DisclosureSEC source: 0001193125-25-278144 · ownership.xml · derivative · entry 6 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2033-10-17 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). F1 · price: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). F4 · derivative.exercise_date: The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period. The options vest and become exercisable in equal monthly installments commencing on October 1, 2023, subject to the Reporting Person's continuous service with the Issuer through each such vesting date. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 23:16 UTC | BillionToOne, Inc. BLLN · Entity 3992 | OtherStock Option (right to buy) · Derivative | 79,400 | Not disclosed Strike: $8.65 | Not disclosed |
DisclosureSEC source: 0001193125-25-278144 · ownership.xml · derivative · entry 5 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,400 Underlying: Class A Common Stock · 79,400 shares Expires 2033-01-18 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). F1 · price: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). F3 · derivative.exercise_date: The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the options vesting on October 24, 2022. The remaining 75%. vest and become exercisable in equal monthly installments over the following three years, subject to the Reporting Person's continuous service with the Issuer through each such vesting date. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 23:16 UTC | BillionToOne, Inc. BLLN · Entity 3992 | OtherStock Option (right to buy) · Derivative | 79,400 | Not disclosed Strike: $8.65 | Not disclosed |
DisclosureSEC source: 0001193125-25-278144 · ownership.xml · derivative · entry 4 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 79,400 shares Expires 2033-01-18 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). F1 · price: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). F3 · derivative.exercise_date: The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the options vesting on October 24, 2022. The remaining 75%. vest and become exercisable in equal monthly installments over the following three years, subject to the Reporting Person's continuous service with the Issuer through each such vesting date. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 23:16 UTC | BillionToOne, Inc. BLLN · Entity 3992 | PurchaseClass A Common Stock | 100 | $60.00 | $6,000.00 |
DisclosureSEC source: 0001193125-25-278144 · ownership.xml · nonDerivative · entry 3 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 700 F2 · kind: These shares of Class A common stock were purchased by the Reporting Person through a directed share program in connection with the Offering. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 23:16 UTC | BillionToOne, Inc. BLLN · Entity 3992 | OtherClass A Common Stock | 600 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-278144 · ownership.xml · nonDerivative · entry 2 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). F1 · price: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 23:16 UTC | BillionToOne, Inc. BLLN · Entity 3992 | OtherCommon Stock | 600 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-278144 · ownership.xml · nonDerivative · entry 1 Lynch Thomas P. · CIK 0001659824 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). F1 · price: Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A common stock immediately prior to the completion of the Issuer's initial public offering of Class A common stock (the "Offering"). Read SEC document |
| January 22, 2021 Filed Jan 27, 2021 02:22 UTC | Nuwellis, Inc. CHFS · Entity 8478 | GrantIncentive Stock Option · Derivative | 7,000 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001567619-21-001560 · doc1.xml · derivative · entry 1 Lynch Thomas P. · CIK 0001659824 · Chief Legal Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 7,000 shares Expires 2031-01-21 F1 · derivative.exercise_date: The options will vest as follows: 25% of the options will vest on the one-year anniversary of the date of grant; the remaining options will vest in 36 equal consecutive monthly increments thereafter, so all will be vested on the four-year anniversary of the date of grant. Read SEC document |
| October 13, 2017 Filed Oct 17, 2017 19:20 UTC | Orexigen Therapeutics, Inc. OREX · Entity 157016 | GrantRestricted Stock Unit (RSU) · Derivative | 69,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-057221 · doc4.xml · derivative · entry 1 Lynch Thomas P. · CIK 0001659824 · EVP, Chief Admin Off, GC & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,600 Underlying: Common Stock · 69,600 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F2 · shares: Reflects an award of restricted stock units ("RSUs"), each representing a contingent right to receive a share of the issuer's common stock upon settlement. F3 · derivative.exercise_date: Twenty-five percent (25%) of the RSUs will vest on each of the first four (4) anniversaries of February 3, 2018 (each, a "Vesting Date"), subject to the reporting person's continued eligibility on each applicable Vesting Date. F3 · derivative.expiration_date: Twenty-five percent (25%) of the RSUs will vest on each of the first four (4) anniversaries of February 3, 2018 (each, a "Vesting Date"), subject to the reporting person's continued eligibility on each applicable Vesting Date. Read SEC document |
| May 31, 2017 Filed Jun 2, 2017 16:47 UTC | Orexigen Therapeutics, Inc. OREX · Entity 157016 | GrantCommon Stock | 1,704 | $1.55 | $2,641.20 |
DisclosureSEC source: 0001209191-17-037332 · doc4.xml · nonDerivative · entry 1 Lynch Thomas P. · CIK 0001659824 · EVP. General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,704 F1 · acquired: Shares acquired under Issuer's 2013 Employee Stock Purchase Plan. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 06:49 UTC | Orexigen Therapeutics, Inc. OREX · Entity 157016 | GrantStock Option · Derivative | 43,500 | Not disclosed Strike: $15.00 | Not disclosed |
DisclosureSEC source: 0001209191-17-008201 · doc4.xml · derivative · entry 2 Lynch Thomas P. · CIK 0001659824 · EVP. General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,500 Underlying: Common Stock · 43,500 shares Expires 2027-02-02 F2 · price: Not Applicable F1 · derivative.exercise_date: 1/48th of the shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the same day of each month following 2/3/2017, so that all of the shares of the stock subject to the option shall be vested on 2/3/2021, subject to the Reporting Person's continued service relationship (whether as an employee, director or consultant) with the Issuer or any parent or subsidiary on each such date, as set forth in the applicable stock option grant notice and stock option agreement for such Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.